The Outsourcing in Clinical Trials DACH 2018 conference will bring innovative and solutions focused content to the DACH biopharmaceutical market. Through in-depth research conducted with local trial sponsors, this event will deliver insight, debate, discussion, presentation and opinion on high priority outsourcing, operations and technology-based themes within the clinical trials space locally. 

With only a handful of places remaining to attend this year’s event, register now and quote MK-BPAD to reserve your place. 

For more information, please click here:

Agenda Highlights for 2018

  • Considerations in observational research - the importance of long-term partnerships (Pamela Bacon, Head of Medical Affairs Communications and Operations, Worldwide Markets at Celgene) 
  • Characterising endpoints of the trials jointly o analyse key milestones in a long-term project (Dr Francois Curtin, COO at GeNeuro SA) 
  • Workshop: Defining key performance indicator's for clarification of trial success (Melanie Eymann, Clinical Outsourcing and Risk Manager at Santhera Pharmaceuticals Ltd) 
  • Characterising end points of the trials jointly to analyse key milestones in a long term project (Francois Curtin, COO, GeNeuro SA) 
  • Exploring advances in technology to improve Patient Recruitment and Retention (Ruggero Fariello, Co-Founder at PharmaFox Therapeutics)
  • Maintaining oversight and monitoring of  solution providers involved in establishing your clinical trials for a secure timeline and better risk management (Jessica Cordes, Director Clinical Operations, Medigene AG) 
  • Integrating Clinical Data Management Systems (CDMS) to Support Data Integrity and Management (Max Horneck, Head of Clinical Data Management and eClinical Systems, Medac Gmb)

Why must you attend?

  • OCT DACH brings recognised experts specifically in the DACH region to discuss, collaborate and network with a variety of key service providers as well as other biopharmaceuticals from innovative and collaborative ideas to help overcome challenges. 
  • This event will deliver insights, debates, discussions, presentations and opinion on high priority outsourcing, operations and technology-based themes within the clinical trial space locally.